Comparative Effectiveness of Rituximab in Combination with Either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
Authors:
- Javier NarváezJNJavier Narváez
- César Díaz-TornéCDCésar Díaz-Torné
- José Miguel RuizJRJosé Miguel Ruiz
- Maria Victoria HernándezMHMaria Victoria Hernández
- Vicens Torrente-SegarraVTVicens Torrente-Segarra
- Sergio RosSRSergio Ros
- Arturo Rodriguez de la SernaASArturo Rodriguez de la Serna
- César Díaz-LópezCDCésar Díaz-López
- Raimon SanmartíRSRaimon Sanmartí
- Joan Miquel NollaJNJoan Miquel Nolla
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 41 (3) , 401-405
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alphaClinical Rheumatology, 2010
- Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritisRheumatology International, 2009
- Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomideAnnals of the Rheumatic Diseases, 2009
- Rituximab for the treatment of rheumatoid arthritisHealth Technology Assessment, 2009
- The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based studyAnnals of the Rheumatic Diseases, 2009
- Leflunomide in rheumatoid arthritis: recommendations through a process of consensusRheumatology, 2005
- Validation of rheumatoid arthritis improvement criteria that include simplified joint countsArthritis & Rheumatism, 1998
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988